Published in Law and Health Weekly, December 29th, 2007
Odyssey Thera entered into the current broad collaborative agreement with Pfizer in September 2006, following the successful completion of two prior collaborations. Under the terms of the multi-year agreement, Pfizer made an up-front payment and agreed to provide research and capital expenditure funding, and to make milestone payments upon the achievement of certain milestones. The first milestone payment stemmed from the creation, in less than one year, of a large panel of high content assays to further enhance Odyssey's...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly